8. QUALITY OF LIFE (QOL) ASSESSMENT IN TWO DOCETAXEL DOSE-SCHEDULES AS SECOND-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): SPANISH LUNG CANCER GROUP (SLCG) PHASE III TRIAL 2005 Conference Paper uri icon

publication date

  • 2005